National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

Published date17 April 2019
Citation84 FR 16025
Record Number2019-07643
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 84 Issue 74 (Wednesday, April 17, 2019)
[Federal Register Volume 84, Number 74 (Wednesday, April 17, 2019)]
                [Notices]
                [Pages 16025-16026]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-07643]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute of Allergy and Infectious Diseases; Notice of
                Closed Meetings
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meetings.
                 The meetings will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Institute of Allergy and Infectious
                Diseases Special Emphasis Panel NIAID Clinical Trial Planning and
                Implementation Grant (R34 and U01).
                 Date: May 23, 2019.
                 Time: 1:00 p.m. to 4:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, 5601 Fishers Lane,
                Rockville, MD 20892 (Telephone Conference Call).
                 Contact Person: Reed Solomon Shabman, Ph.D., Scientific Review
                Officer, Scientific Review Program DEA/NIAID/NIH/DHHS, 5601 Fishers
                Lane, MSC-9823 Rockville, MD 20852, 240-292-0189,
                [email protected].
                 Name of Committee: National Institute of Allergy and Infectious
                Diseases Special Emphasis Panel NIAID Clinical Trial Planning and
                Implementation Grant (R34 and U01).
                 Date: June 6, 2019.
                 Time: 12:00 p.m. to 4:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, 5601 Fishers Lane,
                Rockville, MD 20892 (Telephone Conference Call).
                 Contact Person: Reed Solomon Shabman, Ph.D., Scientific Review
                Officer Scientific Review Program DEA/NIAID/NIH/DHHS,
                [[Page 16026]]
                5601 Fishers Lane, MSC-9823 Rockville, MD 20852, 240-292-0189,
                [email protected].
                 Name of Committee: National Institute of Allergy and Infectious
                Diseases Special Emphasis Panel NIAID Clinical Trial Planning and
                Implementation Grant (R34 and U01).
                 Date: June 7, 2019.
                 Time: 10:00 a.m. to 4:30 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health 5601 Fishers Lane,
                Rockville, MD 20892 (Telephone Conference Call).
                 Contact Person: Reed Solomon Shabman, Ph.D., Scientific Review
                Officer Scientific Review Program DEA/NIAID/NIH/DHHS, 5601 Fishers
                Lane, MSC-9823 Rockville, MD 20852, 240-292-0189,
                [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.855,
                Allergy, Immunology, and Transplantation Research; 93.856,
                Microbiology and Infectious Diseases Research, National Institutes
                of Health, HHS)
                 Dated: April 11, 2019.
                Natasha M. Copeland,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2019-07643 Filed 4-16-19; 8:45 am]
                 BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT